Trial Profile
Comparison of dabigatran etexilat and warfarin in patients with atrial fibrillation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 May 2015
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary) ; Warfarin
- Indications Thromboembolism; Thrombosis
- Focus Adverse reactions
- 22 May 2015 New trial record